Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program

Bone Marrow Transplantation

Volumn 46, Issue 1, 2011, Pages 137-142

  Lavergne, V ^a,b   Ghannoum, M ^c   Weiss, K ^b,d   Roy, J ^d   Beliveau C ^b,d  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Hôpital de Verdun   (Canada)

^d MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

hematopoietic SCT; immunocompromised host; nosocomial transmission; preventive measures; ribavirin

Indexed keywords

IMMUNOGLOBULIN; RIBAVIRIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; HEALTH PROGRAM; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RISK FACTOR; SEASONAL VARIATION;

ADULT; CANADA; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CROSS INFECTION; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; INFECTION CONTROL; MALE; MIDDLE AGED; PATIENT ISOLATION; PNEUMONIA; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SEASONS; UNITED STATES;

EID: 78651366845     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.67     Document Type: Article

References (29)

1. Chemaly RF, Ghosh S, Bodey GP, Rohatgi N, Safdar A, Keating MJ et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: A retrospective study at a major cancer center. Medicine (Baltimore) 2006; 85: 278-287.
2. Ljungman P, Ward KN, Crooks BN, Parker A, Martino R, Shaw PJ et al. Respiratory virus infections after stem cell transplantation: A prospective study from the infectious diseases working party of the european group for blood and marrow transplantation. Bone Marrow Transplant 2001; 28: 479-484.
3. Machado CM, Boas LS, Mendes AV, Santos MF, da Rocha IF, Sturaro D et al. Low mortality rates related to respiratory virus infections after bone marrow transplantation. Bone Marrow Transplant 2003; 31: 695-700.
4. Ebbert JO, Limper AH. Respiratory syncytial virus pneumonitis in immunocompromised adults: Clinical features and outcome. Respiration 2005; 72: 263-269.
5. Hassan IA, Chopra R, Swindell R, Mutton KJ. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: The Christie hospital experience. Bone Marrow Transplant 2003; 32: 73-77.
6. Anaissie EJ, Mahfouz TH, Aslan T, Pouli A, Desikan R, Fassas A et al. The natural history of respiratory syncytial virus infection in cancer and transplant patients: Implications for management. Blood 2004; 103: 1611-1617.
7. Martino R, Porras RP, Rabella N, Williams JV, Ramila E, Margall N et al. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant 2005; 11: 781-796.
8. Ison MG. Respiratory syncytial virus and other respiratory viruses in the setting of bone marrow transplantation. Curr Opin Oncol 2009; 21: 171-176.
9. Boeckh M, Englund J, Li Y, Miller C, Cross A, Fernandez H et al. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin Infect Dis 2007; 44: 245-249.
10. Torres HA, Aguilera EA, Mattiuzzi GN, Cabanillas ME, Rohatgi N, Sepulveda CA et al. Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia. Haematologica 2007; 92: 1216-1223.
11. Ghosh S, Champlin RE, Englund J, Giralt SA, Rolston K, Raad I et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: Combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant 2000; 25: 751-755.
12. de Fontbrune FS, Robin M, Porcher R, Scieux C, de Latour RP, Ferry C et al. Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2007; 45: 1019-1024.
13. Khanna N, Widmer AF, Decker M, Steffen I, Halter J, Heim D et al. Respiratory syncytial virus infection in patients with hematological diseases: Single-center study and review of the literature. Clin Infect Dis 2008; 46: 402-412.
14. Boeckh M. The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br J Haematol 2008; 143: 455-467.
15. Englund JA, Anderson LJ, Rhame FS. Nosocomial transmission of respiratory syncytial virus in immunocompromised adults. J Clin Microbiol 1991; 29: 115-119.
16. Abdallah A, Rowland KE, Schepetiuk SK, To LB, Bardy P. An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: Effect on engraftment and outcome of pneumonia without specific antiviral treatment. Bone Marrow Transplant 2003; 32: 195-203.
17. Champlin RE, Whimbey E. Community respiratory virus infections in bone marrow transplant recipients: The MD anderson cancer center experience. Biol Blood Marrow Transplant 2001; 7(Suppl): 8S-10S.
18. Garcia R, Raad I, Abi-Said D, Bodey G, Champlin R, Tarrand J et al. Nosocomial respiratory syncytial virus infections: Prevention and control in bone marrow transplant patients. Infect Control Hosp Epidemiol 1997; 18: 412-416.
19. Jones BL, Clark S, Curran ET, McNamee S, Horne G, Thakker B et al. Control of an outbreak of respiratory syncytial virus infection in immunocompromised adults. J Hosp Infect 2000; 44: 53-57.
20. Raad I, Abbas J, Whimbey E. Infection control of nosocomial respiratory viral disease in the immunocompromised host. Am J Med 1997; 102 (3A): 48-52; discussion 3-4.
21. Simon A, Khurana K, Wilkesmann A, Muller A, Engelhart S, Exner M et al. Nosocomial respiratory syncytial virus infection: Impact of prospective surveillance and targeted infection control. Int J Hyg Environ Health 2006; 209: 317-324.
22. Guidelines for prevention of nosocomial pneumonia. Centers for Disease Control and Prevention. MMWR Recomm Rep 1997; 46 (RR-1): 1-79.
23. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 2000; 49 (RR-10): 1-125 CE1-7.
24. Machado AF, Sallum MA, Vilas Boas LS, Tateno AF, Machado CM. Molecular characterization of strains of respiratory syncytial virus identified in a hematopoietic stem cell transplant outpatient unit over 2 years: Community or nosocomial infection? Biol Blood Marrow Transplant 2008; 14: 1348-1355.
25. Isaacs D, Dickson H, O'Callaghan C, Sheaves R, Winter A, Moxon ER. Handwashing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus. Arch Dis Child 1991; 66: 227-231.
26. Karanfil LV, Conlon M, Lykens K, Masters CF, Forman M, Griffith ME et al. Reducing the rate of nosocomially transmitted respiratory syncytial virus. Am J Infect Control 1999; 27: 91-96.
27. Krasinski K, LaCouture R, Holzman RS, Waithe E, Bonk S, Hanna B. Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmission. J Pediatr 1990; 116: 894-898.
28. Leclair JM, Freeman J, Sullivan BF, Crowley CM, Goldmann DA. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med 1987; 317: 329-334.
29. Groothuis J, Bauman J, Malinoski F, Eggleston M. Strategies for prevention of RSV nosocomial infection. J Perinatol 2008; 28: 319-323.